Compare CTKB & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTKB | SCZM |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | Canada |
| Employees | N/A | 455 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 603.7M |
| IPO Year | 2021 | N/A |
| Metric | CTKB | SCZM |
|---|---|---|
| Price | $4.47 | $6.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.63 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 834.7K | 361.7K |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,015,000.00 | N/A |
| Revenue This Year | $5.42 | $79.38 |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | ★ 17.67 | N/A |
| 52 Week Low | $3.28 | $5.61 |
| 52 Week High | $6.18 | $17.65 |
| Indicator | CTKB | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 47.66 |
| Support Level | $4.13 | $5.93 |
| Resistance Level | $4.49 | $7.11 |
| Average True Range (ATR) | 0.18 | 0.34 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 31.96 | 64.23 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.